Skip to content

Drug interactions

Lasmiditan + Mitomycin

Severity: Minor

Lasmiditan and Mitomycin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lasmiditan inhibits intestinal P-glycoprotein in vitro, which could increase exposure to P-gp substrates. Clinical relevance for intravenous mitomycin is uncertain and likely small.

What this interaction means in plain words

Lasmiditan and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lasmiditan belongs to Central Nervous System; Mitomycin belongs to Oncology.

Evidence level: Low

Why it happens

Possible P-glycoprotein inhibition by lasmiditan; effect on parenteral mitomycin is theoretical.

What to do

No specific action is usually required; monitor for increased mitomycin toxicity during chemotherapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lasmiditan and Mitomycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lasmiditan with Mitomycin?

MediHelp rates the interaction as minor. Lasmiditan and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lasmiditan inhibits intestinal P-glycoprotein in vitro, which could increase exposure to P-gp substrates. Clinical relevance for intravenous mitomycin is uncertain and likely small.

How serious is the interaction between Lasmiditan and Mitomycin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is usually required; monitor for increased mitomycin toxicity during chemotherapy.

What other medicines interact with Mitomycin?

MediHelp also lists interactions of Mitomycin with, for example, Bacitracin, Deferiprone, Dengue vaccine. The full list is on the Mitomycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in